Compositions and methods for enhanced mucosal delivery of parathyroid hormone

Details for Australian Patent Application No. 2005247369 (hide)

Owner Nastech Pharmaceutical Company Inc.

Inventors Quay, Steven C.; Li, Ching-Yuan; Costantino, Henry R.; Kleppe, Mary S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005247369

PCT Pub. Number WO2005/115441

Priority 60/570,113 10.05.04 US

Filing date 10 May 2005

Wipo publication date 8 December 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/115441 Priority application(s): WO2005/115441

8 January 2009 Alteration of Name

  The name of the applicant has been altered to MDRNA, Inc.

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247373-T-port with swabbable valve

2005247363-Method of manufacturing a covered stent